TAVI Market by Procedure (Transfemoral Implantation, Transapical Implantation, and Transaortic Implantation) - Global Opportunity Analysis and Industry Forecast, 2020 – 2030
SKU ID :NMS-18644764 | Published Date: 01-Mar-2020 | No. of pages: 215Description
TOC
1. INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. RESEARCH METHODOLOGY
1.2.1 SECONDARY RESEARCH
1.2.2 DATA ANALYSIS FRAMEWORK
1.2.3 MARKET SIZE ESTIMATION
1.2.4 FORECASTING
1.2.5 PRIMARY RESEARCH AND DATA VALIDATION
2. MARKET SNAPSHOT, 2019-2030 MILLION USD
2.1. MARKET SNAPSHOT
3. PORTER’S FIVE FORCE MODEL ANALYSIS
4. MARKET DYNAMICS
4.1. GROWTH DRIVERS
4.1.1 DRIVER 1
4.1.2 DRIVER 2
4.1.3 DRIVER 3
4.1.4 DRIVER 4
4.2. CHALLENGES
4.2.1 CHALLENGE 1
4.2.2 CHALLENGE 2
4.3. OPPORTUNITIES
4.3.1 OPPORTUNITY 1
4.3.2 OPPORTUNITY 2
5. GLOBAL TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) MARKET, BY PROCEDURE
5.1. OVERVIEW
5.2. TRANSFEMORAL IMPLANTATION
5.2.1 TRANSFEMORAL IMPLANTATION MARKET, BY REGION
5.2.1.1 North America Transfemoral Implantation Market, By Country
5.2.1.2 Europe Transfemoral Implantation Market, By Country
5.2.1.3 Asia-Pacific Transfemoral Implantation Market, By Country
5.2.1.4 Rest of World Transfemoral Implantation Market, By Country
5.3. TRANSAPICAL IMPLANTATION
5.3.1 TRANSAPICAL IMPLANTATION MARKET, BY REGION
5.3.1.1 North America Transapical Implantation Market, By Country
5.3.1.2 Europe Transapical Implantation Market, By Country
5.3.1.3 Asia-Pacific Transapical Implantation Market, By Country
5.3.1.4 Rest of World Transapical Implantation Market, By Country
5.4. TRANSAORTIC IMPLANTATION
5.4.1 TRANSAORTIC IMPLANTATION MARKET, BY REGION
5.4.1.1 North America Transaortic Implantation Market, By Country
5.4.1.2 Europe Transaortic Implantation Market, By Country
5.4.1.3 Asia-Pacific Transaortic Implantation Market, By Country
5.4.1.4 Rest of World Transaortic Implantation Market, By Country
6. GLOBAL TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) MARKET, BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1 NORTH AMERICA TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) MARKET, BY PROCEDURE
6.2.2 NORTH AMERICA TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI), MARKET BY COUNTRY
6.2.2.1 U.S.
6.2.2.1.1 U.S. Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure
6.2.2.2 Canada
6.2.2.2.1 Canada Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure
6.2.2.3 Mexico
6.2.2.3.1 Mexico Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure
6.3. EUROPE
6.3.1 EUROPE TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) MARKET, BY PROCEDURE
6.3.2 EUROPE TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI), MARKET BY COUNTRY
6.3.2.1 UK
6.3.2.1.1 UK Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure
6.3.2.2 France
6.3.2.2.1 France Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure
6.3.2.3 Germany
6.3.2.3.1 Germany Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure
6.3.2.4 Italy
6.3.2.4.1 Italy Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure
6.3.2.5 Switzerland
6.3.2.5.1 Switzerland Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure
6.3.2.6 Rest of Europe
6.3.2.6.1 Rest of Europe Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure
6.4. ASIA-PACIFIC
6.4.1 ASIA-PACIFIC TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) MARKET, BY PROCEDURE
6.4.2 ASIA-PACIFIC TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI), MARKET BY COUNTRY
6.4.2.1 China
6.4.2.1.1 China Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure
6.4.2.2 India
6.4.2.2.1 India Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure
6.4.2.3 Japan
6.4.2.3.1 Japan Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure
6.4.2.4 Rest of Asia-Pacific
6.4.2.4.1 Rest of Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure
6.5. REST OF WORLD
6.5.1 REST OF WORLD TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) MARKET, BY PROCEDURE
6.5.2 REST OF WORLD TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI), MARKET BY COUNTRY
6.5.2.1 Brazil
6.5.2.1.1 Brazil Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure
6.5.2.2 South Africa
6.5.2.2.1 South Africa Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure
6.5.2.3 Israel
6.5.2.3.1 Israel Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure
6.5.2.4 Saudi Arabia
6.5.2.4.1 Saudi Arabia Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure
6.5.2.5 Remaining Countries
6.5.2.5.1 Remaining Countries Transcatheter Aortic Valve Implantation (TAVI) Market, By Procedure
7. COMPANY PROFILES
7.1. ABBOTT LABORATORIES
7.1.1 COMPANY OVERVIEW
7.1.2 COMPANY SNAPSHOT
7.1.3 OPERATING BUSINESS SEGMENTS
7.1.4 PRODUCT PORTFOLIO
7.1.5 BUSINESS PERFORMANCE
7.1.6 KEY STRATEGIC MOVES AND DEVELOPMENT
7.2. BOSTON SCIENTIFIC CORPORATION
7.2.1 COMPANY OVERVIEW
7.2.2 COMPANY SNAPSHOT
7.2.3 OPERATING BUSINESS SEGMENTS
7.2.4 PRODUCT PORTFOLIO
7.2.5 BUSINESS PERFORMANCE
7.2.6 KEY STRATEGIC MOVES AND DEVELOPMENT
7.3. BRACCO S.P.A.
7.3.1 COMPANY OVERVIEW
7.3.2 COMPANY SNAPSHOT
7.3.3 OPERATING BUSINESS SEGMENTS
7.3.4 PRODUCT PORTFOLIO
7.3.5 BUSINESS PERFORMANCE
7.3.6 KEY STRATEGIC MOVES AND DEVELOPMENT
7.4. EDWARDS LIFESCIENCES CORPORATION
7.4.1 COMPANY OVERVIEW
7.4.2 COMPANY SNAPSHOT
7.4.3 OPERATING BUSINESS SEGMENTS
7.4.4 PRODUCT PORTFOLIO
7.4.5 BUSINESS PERFORMANCE
7.4.6 KEY STRATEGIC MOVES AND DEVELOPMENT
7.5. JENAVALVE TECHNOLOGY, INC.
7.5.1 COMPANY OVERVIEW
7.5.2 COMPANY SNAPSHOT
7.5.3 OPERATING BUSINESS SEGMENTS
7.5.4 PRODUCT PORTFOLIO
7.5.5 BUSINESS PERFORMANCE
7.5.6 KEY STRATEGIC MOVES AND DEVELOPMENT
7.6. JC MEDICAL, INC.
7.6.1 COMPANY OVERVIEW
7.6.2 COMPANY SNAPSHOT
7.6.3 OPERATING BUSINESS SEGMENTS
7.6.4 PRODUCT PORTFOLIO
7.6.5 BUSINESS PERFORMANCE
7.6.6 KEY STRATEGIC MOVES AND DEVELOPMENT
7.7. MEDTRONIC PLC.
7.7.1 COMPANY OVERVIEW
7.7.2 COMPANY SNAPSHOT
7.7.3 OPERATING BUSINESS SEGMENTS
7.7.4 PRODUCT PORTFOLIO
7.7.5 BUSINESS PERFORMANCE
7.7.6 KEY STRATEGIC MOVES AND DEVELOPMENT
7.8. MERIL LIFE SCIENCES PVT. LTD.
7.8.1 COMPANY OVERVIEW
7.8.2 COMPANY SNAPSHOT
7.8.3 OPERATING BUSINESS SEGMENTS
7.8.4 PRODUCT PORTFOLIO
7.8.5 BUSINESS PERFORMANCE
7.8.6 KEY STRATEGIC MOVES AND DEVELOPMENT
7.9. NVT AG
7.9.1 COMPANY OVERVIEW
7.9.2 COMPANY SNAPSHOT
7.9.3 OPERATING BUSINESS SEGMENTS
7.9.4 PRODUCT PORTFOLIO
7.9.5 BUSINESS PERFORMANCE
7.9.6 KEY STRATEGIC MOVES AND DEVELOPMENT
7.10. VENUS MEDTECH, INC.
7.10.1 COMPANY OVERVIEW
7.10.2 COMPANY SNAPSHOT
7.10.3 OPERATING BUSINESS SEGMENTS
7.10.4 PRODUCT PORTFOLIO
7.10.5 BUSINESS PERFORMANCE
7.10.6 KEY STRATEGIC MOVES AND DEVELOPMENT
Tables & Figures
Companies
- PRICE
-
$3975$6975